Cancer prevention for people who do not want to wait for a diagnosis

A six-dose preventive course that trains the immune system against 14 major solid tumours, built on a personal risk assessment and backed by a ten-year coverage plan. Delivered worldwide.

Four groups of people ask us about prevention

Family historyCancer in parents, siblings or grandparents, or a known hereditary predisposition.

Weakened immunityAn immune system that has become slower with age, illness or treatment. Immune competence is measured before the course begins.

Chronic inflammation and lifestyleSmoking, alcohol, lack of sleep, long-term stress. Chronic inflammation, visible in markers such as IL-6 and TNF-alpha, is one of the strongest known drivers of tumour development.

After cancerPeople whose cancer has been treated and who want to lower the risk of a recurrence or a second tumour.

A nano-vaccine that trains the immune system before a tumour exists

The course consists of six doses of an mTORC1 CpG nano-vaccine. CpG is a molecular signal that switches on the innate immune system; carried in nanoparticles together with antigens shared by 14 common solid tumours, it teaches immune cells to recognise and remove early cancer cells. At the same time, the mTORC1 growth pathway, which drives tumour cells, is turned down.

Six dosesGiven by injection over the course, where you live or at one of our locations. Each visit takes under an hour.

PersonalThe composition follows your risk assessment: family history, immune status, inflammation markers.

MeasuredImmune and inflammation markers before, during and after the course show what the vaccine has changed.

Follow-upAnnual check-ups during the ten-year coverage period, with access to multidisciplinary consultation if anything is found.

Preventive vaccination of this kind does not yet have controlled long-term data. The coverage plan exists for that reason: if cancer is diagnosed despite the course, the plan pays.

Coverage

Targeted protection against 14 major solid tumours

Lung

Colorectal

Breast

Prostate

Liver

Stomach

Pancreatic

Oesophageal

Ovarian

Kidney

Bile duct

Brain

Melanoma

Osteosarcoma

USD 42,000 for the six-dose course, with ten years of coverage

CourseSix doses, risk assessment, personalised composition, follow-up check-ups: USD 42,000.

Coverage rightsTen years from the last dose. If one of the 14 tumour types is diagnosed during that time, the plan pays out.

PayoutUSD 224,000 to 895,000 depending on your personalised plan, up to a maximum of USD 2.24 million.

Treatment supportMultidisciplinary consultation, access to new and overseas specialty drugs, and overseas specialty drug coverage of USD 60,000.

Your termsThe coverage plan is a separate contract. Its provider, conditions, waiting periods and exclusions are set out in your plan documents before you pay.

How it works

Four steps from risk assessment to coverage

Risk assessment

Family history, immune status, inflammation markers and lifestyle. A questionnaire and a blood sample, taken where you live.

Personal plan

Composition of the course and the coverage amount, in writing, with price and terms. You decide.

Six doses

Delivered worldwide and given by injection, at home with a physician or at one of our locations.

Ten years of coverage

Annual check-ups, markers tracked, coverage active. If anything is found, consultation and treatment support start at once.

Request a risk assessment Questions about prevention

Start with a risk assessment

Request a risk assessment